This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Michael J Iammarino: Innovator in Recombinant Insulin Production
Introduction
Michael J Iammarino is a notable inventor based in Kenilworth, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant insulin. His innovative approach has led to advancements in the purification processes used in insulin manufacturing.
Latest Patents
Iammarino holds a patent for a process for preparing recombinant insulin using microfiltration. This patent describes the use of two tandem microfiltration (MF) steps in a single downstream purification unit operation. This method effectively reduces both soluble and insoluble impurities while exchanging the insulin product into a suitable buffer for downstream purification.
Career Highlights
Michael J Iammarino is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions in the pharmaceutical industry, particularly in the area of insulin production.
Collaborations
Iammarino has collaborated with notable colleagues such as Sean S Gant and Kristi Kerchner. These partnerships have contributed to the advancement of research and development in the field of biotechnology.
Conclusion
Michael J Iammarino's contributions to the field of recombinant insulin production highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the biotechnology industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile